Published in J Neurol Neurosurg Psychiatry on July 01, 1999
Intravenous immunoglobulin in neurological disease: a specialist review. J Neurol Neurosurg Psychiatry (2002) 1.13
Axon loss is an important determinant of weakness in multifocal motor neuropathy. J Neurol Neurosurg Psychiatry (2006) 0.93
On the early diagnosis of IVIg-responsive chronic multifocal acquired motor axonopathy. J Neurol (2004) 0.81
Management of motor neurone disease. Postgrad Med J (2002) 0.81
Multifocal motor neuropathy, multifocal acquired demyelinating sensory and motor neuropathy, and other chronic acquired demyelinating polyneuropathy variants. Neurol Clin (2013) 0.80
Asymmetric Acquired Demyelinating Polyneuropathies: MMN and MADSAM. Curr Treat Options Neurol (2001) 0.77
Is IVIg therapy warranted in progressive lower motor neuron syndromes without conduction block? Neurology (2013) 0.76
New hope for patients with pure lower motor neurons syndromes. J Neurol Neurosurg Psychiatry (2000) 0.75
Test-retest reliability of hand-held dynamometry during a single session of strength assessment. Phys Ther (1986) 2.59
Multifocal motor neuropathy with conduction block: is it a distinct clinical entity? Neurology (1992) 1.93
Electrophysiologic findings in multifocal motor neuropathy. Neurology (1997) 1.70
Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry (1995) 1.31
Multifocal motor neuropathy with conduction block: a study of 24 patients. J Neurol Neurosurg Psychiatry (1995) 1.06
A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol (1996) 1.03
Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies: a meta-analysis. Neurology (1995) 0.97
Massive nerve root enlargement in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry (1996) 0.94
Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates. Neurology (1997) 0.94
Antiganglioside antibodies do not necessarily play a role in multifocal motor neuropathy. Muscle Nerve (1994) 0.89
Magnetic resonance neurography for cervical radiculopathy: a preliminary report. Neurosurgery (1996) 0.87
Long term follow up of multifocal motor neuropathy with conduction block under treatment. J Neurol Neurosurg Psychiatry (1997) 0.87
Improvement of multifocal motor neuropathy during long-term weekly treatment with human immunoglobulin. Neurology (1995) 0.85
The use of self infused intravenous immunoglobulin home therapy in the treatment of acquired chronic demyelinating neuropathies. J Neurol Neurosurg Psychiatry (1997) 0.83
Intravenous immunoglobulin treatment in lower motor neuron disease associated with highly raised anti-GM1 antibodies. J Neurol Neurosurg Psychiatry (1997) 0.81
Prevalence of specific language impairment in kindergarten children. J Speech Lang Hear Res (1997) 6.37
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol (1997) 5.89
Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet (1996) 4.11
Targeted deletion of 5'HS2 of the murine beta-globin LCR reveals that it is not essential for proper regulation of the beta-globin locus. Genes Dev (1995) 4.11
Characteristics of firearms involved in fatalities. JAMA (1996) 3.95
Cellular location of enzymes involved in chondroitin sulfate breakdown by Bacteroides thetaiotaomicron. J Bacteriol (1980) 3.54
Site-specific mutagenesis of Agrobacterium Ti plasmids and transfer of genes to plant cells. J Mol Appl Genet (1981) 3.31
Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet (1992) 3.30
Interspersed requests: a nonaversive procedure for reducing aggression and self-injury during instruction. J Appl Behav Anal (1991) 3.03
Loss of consciousness and post-traumatic stress disorder. A clue to aetiology and treatment. Br J Psychiatry (1998) 2.76
Safe, live Vibrio cholerae vaccines? Vaccine (1988) 2.74
Underprediction of human skin erythema at low doses per fraction by the linear quadratic model. Radiother Oncol (1996) 2.69
Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain (1992) 2.64
Psychological stress and burnout in medical students: a five-year prospective longitudinal study. J R Soc Med (1998) 2.59
OntologyTraverser: an R package for GO analysis. Bioinformatics (2004) 2.56
Do patients in whom myocardial infarction has been ruled out have a better prognosis after hospitalization than those surviving infarction? N Engl J Med (1980) 2.42
Optimal methods for guideline implementation: conclusions from Leeds Castle meeting. Med Care (2001) 2.41
Prevalence of faecal incontinence in adults aged 40 years or more living in the community. Gut (2002) 2.41
The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation. Mol Microbiol (1999) 2.37
Some methodological problems in studying consultations in general practice. J R Coll Gen Pract (1976) 2.33
Pseudobattering in Vietnamese children. Pediatrics (1976) 2.32
Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis (2004) 2.29
Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (1998) 2.28
Production of an S RNase with dual specificity suggests a novel hypothesis for the generation of new S alleles. Plant Cell (1999) 2.28
The long-term follow-up of patients undergoing saphenous vein bypass surgery. Circulation (1974) 2.19
Depolarization and cAMP elevation rapidly recruit TrkB to the plasma membrane of CNS neurons. Neuron (1998) 2.18
An estimate of amyotrophic lateral sclerosis heritability using twin data. J Neurol Neurosurg Psychiatry (2010) 2.14
Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke. Neurology (1998) 2.11
Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab (1996) 2.06
Social class variations in health care and in the nature of general practitioner consultations. Sociol Rev Monogr (1976) 2.03
Laparoscopic versus open total mesorectal excision with anal sphincter preservation for low rectal cancer. Surg Endosc (2004) 2.01
Diffusion tensor MRI assesses corticospinal tract damage in ALS. Neurology (1999) 1.98
Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders. Br J Ophthalmol (1998) 1.95
Crystal structure of a phosphorylated Smad2. Recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-beta signaling. Mol Cell (2001) 1.95
Low dose rate teletherapy and tumour response. Australas Radiol (1993) 1.94
The prehospital course of patients with chest pain. Analysis of the prodromal, symptomatic, decision-making, transportation and emergency room periods. Am J Med (1978) 1.92
Delay in the diagnosis of pediatric brain tumors. Am J Dis Child (1986) 1.83
Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia. Neurosci Lett (1992) 1.82
Psychiatric morbidity among adults living in private households, 2000. Int Rev Psychiatry (2004) 1.81
Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS). Neuropsychologia (2000) 1.80
Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord (2002) 1.80
Sporadic Creutzfeldt-Jakob disease in a 16-year-old in the UK. Lancet (1995) 1.78
Comparison of IS1, IS2 and IS3 copy number in Escherichia coli strains K-12, B and C. Gene (1981) 1.78
Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene. J Cell Physiol (2000) 1.76
New VAPB deletion variant and exclusion of VAPB mutations in familial ALS. Neurology (2008) 1.76
Streptococcus iniae, a human and animal pathogen: specific identification by the chaperonin 60 gene identification method. J Clin Microbiol (1998) 1.75
Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis: correlation between genotype and clinical features. J Neurol Neurosurg Psychiatry (1996) 1.74
Enzymatic profile of Pseudomonas maltophilia. J Clin Microbiol (1982) 1.73
Effect of the somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men. Digestion (1987) 1.73
The natural history of acute painful neuropathy in diabetes mellitus. J Neurol Neurosurg Psychiatry (1983) 1.72
Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology (2009) 1.71
A partial restriction map of the proA-purE region of the Escherichia coli K12 chromosome. Gene (1983) 1.70
The carpal tunnel syndrome: can we do better? J Hand Surg Br (1988) 1.69
Proviral insertions induce the expression of bone-specific isoforms of PEBP2alphaA (CBFA1): evidence for a new myc collaborating oncogene. Proc Natl Acad Sci U S A (1997) 1.69
Volumetric analysis reveals corticospinal tract degeneration and extramotor involvement in ALS. Neurology (2001) 1.68
Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis. Eur J Cancer (2001) 1.65
Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol (2013) 1.65
Respiratory aspects of neurological disease. J Neurol Neurosurg Psychiatry (1999) 1.61
Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes. J Clin Invest (1993) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Treatment of diabetic neuropathy with gamma-linolenic acid. The gamma-Linolenic Acid Multicenter Trial Group. Diabetes Care (1993) 1.60
Differential corticospinal tract degeneration in homozygous 'D90A' SOD-1 ALS and sporadic ALS. J Neurol Neurosurg Psychiatry (2011) 1.55
Part-time training: experience in the Northern Region. Public Health (1984) 1.55
Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum Mol Genet (1999) 1.54
Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia. Br J Psychiatry (2004) 1.54
The p53--Mdm2--HAUSP complex is involved in p53 stabilization by HAUSP. Oncogene (2007) 1.54
VAMP8/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA. J Thromb Haemost (2009) 1.54
A new classification and diagnostic criteria for invasive fungal sinusitis. Arch Otolaryngol Head Neck Surg (1997) 1.54
Endoscopic band ligation of bleeding dieulafoy lesions: the best therapeutic strategy. Endoscopy (2006) 1.53
Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression. Cancer Res (2000) 1.53
Amyotrophic lateral sclerosis in South-East England: a population-based study. The South-East England register for amyotrophic lateral sclerosis (SEALS Registry). Neuroepidemiology (2007) 1.52
The morphological spectrum of T-prolymphocytic leukaemia. Br J Haematol (1986) 1.52
Malignancies metastatic to the pleura. Invest Radiol (1990) 1.51
Analysis of genetic variability within Thelazia callipaeda (Nematoda: Thelazioidea) from Europe and Asia by sequencing and mutation scanning of the mitochondrial cytochrome c oxidase subunit 1 gene. Mol Cell Probes (2005) 1.50
Ethical and clinical issues in the use of home non-invasive mechanical ventilation for the palliation of breathlessness in motor neurone disease. Thorax (1999) 1.50
Colonization of the gut of the blue crab (Callinectes sapidus) by Vibrio cholerae. Appl Environ Microbiol (1986) 1.50
Rat pregnane X receptor: molecular cloning, tissue distribution, and xenobiotic regulation. Arch Biochem Biophys (1999) 1.49
Role of the glucosamine pathway in fat-induced insulin resistance. J Clin Invest (1997) 1.49
Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes. Diabetes (1996) 1.49
Changes in health-related quality of life following coronary artery bypass graft surgery. Ann Thorac Surg (2001) 1.48
A potassium contribution to the response of the barnacle photoreceptor. J Physiol (1977) 1.48
Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial. Neurology (2006) 1.47
Microscopic dynamics of liquid aluminum oxide. Science (2003) 1.46
EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. Eur J Neurol (2005) 1.45
Neuropeptide variability in man. Eur J Clin Invest (2000) 1.45
Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain (2001) 1.44
Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway. Cancer Res (2001) 1.43
Accidental nail gun injuries to the heart: diagnostic, treatment, and epidemiological considerations. J Trauma (2005) 1.43
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Influence of HLA matching and associated factors on aortic valve homograft function. J Heart Valve Dis (2000) 1.41
Mutations in all five exons of SOD-1 may cause ALS. Ann Neurol (1998) 1.40
2.9 A crystal structure of ligand-free tryptophanyl-tRNA synthetase: domain movements fragment the adenine nucleotide binding site. Protein Sci (2000) 1.40
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Is the secretion of atrial natriuretic peptide in man under neural control? Eur Heart J (2000) 1.39
Electrophysiological localization of ulnar nerve lesions. J Neurol Neurosurg Psychiatry (1969) 1.38
Systematic review and evaluation of methods of assessing urinary incontinence. Health Technol Assess (2006) 1.37
A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study Group. Neurology (1998) 1.37
Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene. J Clin Invest (1997) 1.37